CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure · Other events
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4/A Open-market buy Chief Medical Officer bought 5,000 shares at $5.18 ($25,900)
- 4/A Open-market buy Chief Medical Officer bought 4,694 shares at $5.95 ($27,925)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Medical Officer bought 5,000 shares at $5.18 ($25,900)
- 4 Open-market buy Chief Financial Officer bought 400 shares at $5.83 ($2,330)
- 4 Open-market buy Chief Medical Officer bought 4,694 shares at $5.95 ($27,925)
- 4 Open-market buy Chief Executive Officer bought 6,000 shares at $6.50 ($39,000)
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Director bought 10,000 shares at $6.05 ($60,500)
- 4 Open-market buy Director bought 1,468 shares at $6.40 ($9,395)
- 4 Open-market buy Director bought 2,532 shares at $6.20 ($15,698)
Page 58 of 76 · 1,519 filings